Lapatinib is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways.. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2).
Trade Information
FOB Port
Mumbai
Payment Terms
Western Union, Cheque, Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD)
Delivery Time
1 Days
Packaging Details
30 TABLETS
Main Export Market(s)
Western Europe, Eastern Europe, South America, Central America, Australia, Asia